Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP223415.RAm2NdEzOUsrURVpGXZbo7TlDpYCb8901klH_EO-NhRg4130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP223415.RAm2NdEzOUsrURVpGXZbo7TlDpYCb8901klH_EO-NhRg4130_assertion type Assertion NP223415.RAm2NdEzOUsrURVpGXZbo7TlDpYCb8901klH_EO-NhRg4130_head.
- NP223415.RAm2NdEzOUsrURVpGXZbo7TlDpYCb8901klH_EO-NhRg4130_assertion description "[CYP3A5 polymorphisms were rapidly determined using polymerase chain reaction-restriction fragment length polymorphism analysis in 113 Taiwanese patients with hepatoma, 70 with cervical cancer, 92 with breast cancer, 82 with oral cancer, 90 with thyroid cancer, 133 with lung cancer, and 270 healthy controls.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP223415.RAm2NdEzOUsrURVpGXZbo7TlDpYCb8901klH_EO-NhRg4130_provenance.
- NP223415.RAm2NdEzOUsrURVpGXZbo7TlDpYCb8901klH_EO-NhRg4130_assertion evidence source_evidence_literature NP223415.RAm2NdEzOUsrURVpGXZbo7TlDpYCb8901klH_EO-NhRg4130_provenance.
- NP223415.RAm2NdEzOUsrURVpGXZbo7TlDpYCb8901klH_EO-NhRg4130_assertion SIO_000772 12822676 NP223415.RAm2NdEzOUsrURVpGXZbo7TlDpYCb8901klH_EO-NhRg4130_provenance.
- NP223415.RAm2NdEzOUsrURVpGXZbo7TlDpYCb8901klH_EO-NhRg4130_assertion wasDerivedFrom befree-20140225 NP223415.RAm2NdEzOUsrURVpGXZbo7TlDpYCb8901klH_EO-NhRg4130_provenance.
- NP223415.RAm2NdEzOUsrURVpGXZbo7TlDpYCb8901klH_EO-NhRg4130_assertion wasGeneratedBy ECO_0000203 NP223415.RAm2NdEzOUsrURVpGXZbo7TlDpYCb8901klH_EO-NhRg4130_provenance.